Pier Capital LLC acquired a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 83,625 shares of the company’s stock, valued at approximately $8,024,000. Pier Capital LLC owned 0.10% of HealthEquity at the end of the most recent quarter.
Other hedge funds have also recently modified their holdings of the company. Arcadia Investment Management Corp MI bought a new position in HealthEquity during the 4th quarter valued at approximately $26,000. Smartleaf Asset Management LLC increased its holdings in shares of HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after acquiring an additional 98 shares in the last quarter. UMB Bank n.a. raised its position in shares of HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after purchasing an additional 164 shares during the last quarter. Skandinaviska Enskilda Banken AB publ boosted its stake in HealthEquity by 1,934.8% in the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock worth $45,000 after purchasing an additional 445 shares in the last quarter. Finally, Lindbrook Capital LLC boosted its stake in HealthEquity by 27.6% in the 4th quarter. Lindbrook Capital LLC now owns 750 shares of the company’s stock worth $72,000 after purchasing an additional 162 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.
HealthEquity Stock Up 6.4 %
Shares of HQY opened at $90.32 on Tuesday. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The company has a market cap of $7.81 billion, a PE ratio of 82.86, a P/E/G ratio of 1.60 and a beta of 0.62. The business has a fifty day moving average of $104.67 and a 200 day moving average of $95.84.
Analyst Upgrades and Downgrades
Read Our Latest Research Report on HealthEquity
Insider Buying and Selling
In related news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now owns 78,219 shares of the company’s stock, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 2.20% of the stock is owned by corporate insiders.
HealthEquity Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Articles
- Five stocks we like better than HealthEquity
- How to trade using analyst ratings
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- How to Calculate Retirement Income: MarketBeat’s Calculator
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.